Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Shares Purchased by E Fund Management Co Ltd tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Lisanti Capital Growth LLC boosted its holdings in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) by 100.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 100,245 shares of the company’s stock after acquiring an additional 50,265 shares during the period. Lisanti Capital […]
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eleven ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 12 month […]
Short Interest in Crinetics Pharmaceuticals, Inc (NASDAQ:CRNX) Rises By 6 3% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its price target raised by Jonestrading from $52.00 to $56.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock. Several other brokerages have also commented on CRNX. Citigroup started coverage on Crinetics Pharmaceuticals in a research […]